Fabián AM, Trigo P, Lendoire J, Imventarza O, Parisi C

Language: English
References: 23
Page: 171-174
PDF size: 100.28 Kb.

Text Extraction

FAP is an autosomal dominant inherited disease, characterized by systemic deposition of amyloid fibrils in various tissues. The purpose of this study is to describe the gross and microscopic findings of the explanted livers for FAP.
10 patients were transplanted for FAP at our institution. Diagnosis was supported by positive familiar history, clinical data and detection of mutated TTR by electrospray ionization mass spectrometry with Val30Met mutation verified by PCR. All the explanted livers were photographed, fixed in formol and processed according to protocol. Later they were examined with HyE, reticulin, PAS diastasa, Masson trichromic, Congo red with polarised light and immunoreactivity against TTR. The gross aspect was normal. We obtained multiple samples representative of the organ and the hepatic hilium. All of the patients presented with deposits of amyloid substance in the lymph nodes and the nerves of the hepatic hilium These deposits were Congo red positive with a greenish birefringence to polarized light Deposits show immunoreactivity with antihuman TTR. Whereas liver transplantation restores hepatic function in patients with cirrhosis, liver transplantation cures the FAP patient of their genetic defect. Domino transplantation is a procedure in which the index patient receives an organ, while the explanted organ is reused for transplantation into another patient. In conclusion, exclusion of hepatic amyloid deposits which can cause functional alterations in the FAP liver is vital; and is important to study the explanted livers of patients with FAP to confirm the results of the scarce published series.

REFERENCES

1. Benson MD. Amyloidosis. In: Scriver CR, Beaudet AK, Sly WS, Valle D, eds. The metabolic and molecular basis of inherited disease. New York: Mc Graw-Hill, 1995: 4159.

2. Saraiva MJ, Costa PP, Goodman DS. Genetic expression of transthyretin mutation in typical and late onset Portuguese families with familial amyloidotic polyneuropathy. Neurology 1986; 36: 1413-1417.

3. Pomfret PA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, Falk RH, et al. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998; 65: 918-925.

4. Parrilla P, Ramirez P, Bueno FS, Robles R, Acosta F, Miras M, Pons JA, et al. Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy. Br J Surg 1995; 82: 825-828.

5. Ii S, Minnerath S, Ii K, Dyck PJ, Sommer SS. Two-tiered DNA-based diagnosis of transthyretin amyloidosis reveals two novel point mutations. Neurology 1991; 41(6): 893-8.

6. Schmidt HH, Nasham B, Pröpsting MJ, Nakasato M, Flemming P, Kubicka S, Boker K, et al. Familial amyloidotic polyneuropathy: Domino liver transplantation. J Hepatology 1999; 30: 293-298.

7. Hawkins PN, Rydh A, Persey MR. SAP scintigraphy in 43 patients with TTR associated FAP. Neuromusc Disord 1996; 6: 23.

8. Gertz M, Kyle M, Thibodeau S. Familial amyloidosis: A study of 52 north american born patients examined during a thirty year period. Mayo Clin Proc 1992; 67: 428.

9. Ikeda S, Hnayu N, Hongo M, Yoshioka J, Oguchi H, Yanagisawa N, Kobayashi T, et al. Hereditary generalized amyloidosis with polyneuropathy. Clinicopathological study of 65 japanese patients. Brain 1987; 110: 315-347.

10. Bhatia K, Reilly M, AdamsD, Davis MB, Hawkes CH, Thomas PK, Said G, et al. Transthyretin gene mutations in british and french patients with amyloid neuropathy. J Neurol 1993; 56: 694-697.

11. Bergfeld BL, Olofsson BO, Edhag KO. Electrophysiologic evaluation of the cardiac conduction system and its autonomic regulation in familial amyloid polyneuropathy. Am J Cardiol 1985; 56: 647-52.

12. Lendoire J, Trigo P, Aziz H, Cueto G, Ando Y, Ohlsson PI, Suhr OB, et al. Liver transplantation in transthyretin familial amyloid polyneuropathy: first report from Argentina. Amyloid 1999; 6: 297-300.

13. Lobato L, Beirao I, Guimaraes SM, Droz D, Guimaraes S, Grünfeld JP, Noel LH. Familial Amyloid Polyneuropathy Type I (portuguese): Distribution and characterization of renal amyloid deposits. Am J Kid Dis 1998; 31: 940-946.

14. Lewis WD, Skinner M, Simms RW, Jones LA, Cohen AS, Jenkins RL. Orthotopic liver transplantation for familial amyloidotic polyneuropathy. Clin Transplant 1993; 7: 1.

15. Hanyu N, Ikeda S, Nakadai A, Yanagisawa N, Powell HC. Peripheral nerve pathological findings in familial amyloid plyneuropathy: a correlative of proximal sciatic nerve and sural nerve lesions. Ann Neurol 1989; 25: 340-350.

16. Imventarza O, Lendoire J, Bianco G, Saul J, Braslavsky G, Trigo P, Cueto G, et al. Development of an adult liver transplant program in a public hospital in Argentina. Transplant Proc 1998; 30: 2878-9.

17. Arpa Gutierrez J, Morales C, Lara M, Munoz C, Garcia-Rojo M, Caminero A, Gutierrez M. Type I familial amyloid polyneuropathy and pontine haemorrhage. Acta Neuropathol (Berl) 1993; 86(5): 542-5.

18. Takahashi K, Yi S, Kimura Y, Araki S. Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: a clinicopathologic, histochemical, immunohistochemical, and ultrastructural study. Hum Pathol 1991; 22(6): 519-27.

19. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (1). N Engl J Med 1989; 321: 1092-1999.

20. Schmidt HH, Hill S, Makariou EV, Feuerstein IM, Dugi KA, Hoeg JM. Relation of cholesterol year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia. Am J Cardiol 1996; 77: 575-80.

21. Lendoire J, Trigo P, Azíz H, Scazzuso F, Cueto G, Imventarza O. Improvement of transthyretin familial amyloidotic polyneuropathy after liver transplantation in Argentinian patients. Transplant Proc 1999; 31: 3058-9.

22. Stangou AJ, Heaton ND, Rela M, Pepys MB, Hawkins PN, Williams R. Domino hepatic transplantation using the liver from a patient with familial amyloid polineuropathy. Transplantation 1998; 65: 1496-1498.

23. Parrilla P, Ramírez P, Andreu LF, Bueno SF, Robles R, Miras M, Acosta F, et al. Long-term results of liver transplantation in Familial Amyloidotic Polyneuropathy Type I. Transplantation 1997; 64: 646-64.